Nephros (NEPH) Current Deferred Revenue (2010 - 2017)

Nephros' Current Deferred Revenue history runs 8 years deep, the most recent figure standing at $70000.0 for Q4 2017.

• In Q4 2017, Current Deferred Revenue fell 69.16% year-over-year to $70000.0; the TTM figure through Dec 2017 stood at $70000.0 (down 69.16% YoY), while the FY2017 annual figure was $70000.0, down 69.16% from the prior year.
• Current Deferred Revenue was $70000.0 for Q4 2017 at Nephros, roughly flat from $70000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $873000.0 in Q2 2014 to a low of $70000.0 in Q1 2015.
• Historically, Current Deferred Revenue has averaged $283600.0 across 5 years, with a median of $70000.0 in 2015.
• The sharpest annual moves came in 2015 and 2016: Current Deferred Revenue plunged 91.98% in 2015, then jumped 224.29% in 2016.
• A 5-year view of Current Deferred Revenue shows it stood at $703000.0 in 2013, then plunged by 30.73% to $487000.0 in 2014, then plunged by 85.63% to $70000.0 in 2015, then surged by 224.29% to $227000.0 in 2016, then sank by 69.16% to $70000.0 in 2017.
• The last three Current Deferred Revenue figures came in at $70000.0 (Q4 2017), $70000.0 (Q3 2017), and $70000.0 (Q2 2017), per Business Quant data.